Assura (LON:AGR) Reaches New 52-Week Low – Here’s What Happened

Assura Plc (LON:AGRGet Free Report) shares hit a new 52-week low on Wednesday . The company traded as low as GBX 36.78 ($0.45) and last traded at GBX 36.82 ($0.45), with a volume of 1627374 shares changing hands. The stock had previously closed at GBX 37.10 ($0.46).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 51 ($0.63) target price on shares of Assura in a research report on Tuesday, September 17th.

Check Out Our Latest Research Report on Assura

Assura Trading Down 1.0 %

The company has a debt-to-equity ratio of 85.04, a quick ratio of 2.84 and a current ratio of 0.89. The company has a market cap of £1.18 billion, a price-to-earnings ratio of -3,629.80, a P/E/G ratio of 3.60 and a beta of 0.37. The company’s fifty day moving average is GBX 38.72 and its two-hundred day moving average is GBX 40.45.

Assura Dividend Announcement

The firm also recently announced a dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, December 12th will be issued a dividend of GBX 0.84 ($0.01) per share. The ex-dividend date is Thursday, December 12th. This represents a dividend yield of 2.12%. Assura’s dividend payout ratio (DPR) is presently -30,000.00%.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Read More

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.